Pronovotx
ProNovo Therapeutics develops novel, precision therapeutics targeting unmet medical needs in neuropsychiatric disorders like Major Depressive Disorder and Schizophrenia. The company integrates genetic susceptibility and prognostic biomarkers into its de-risked medicine strategy to create high-impact treatments. Its pipeline includes first-in-class and best-in-class opportunities for depression and schizophrenia, respectively.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- ProNovo Therapeutics develops novel, precision therapeutics targeting unmet medical needs in neuropsychiatric disorders like Major Depressive Disorder and Schizophrenia. The company integrates genetic susceptibility and prognostic biomarkers into its de-risked medicine strategy to create high-impact treatments. Its pipeline includes first-in-class and best-in-class opportunities for depression and schizophrenia, respectively.